when the stock ran to 480, all the good news about their alzheimer drug was priced in. now at 402, all that good news has been taken out. I would not agree with what you are saying. don't be fooled.
why does this station constantly repeat every time that biotechs are up or when their is M & A in this sector with the question, "Is there a bubble brewing in this sector? I don't hear that with Amzn, Tsla, or Nflx and none of those make any money.
and? you didn't finish your thought. finish reading the note put out by Barclays.
wouldn't be too concerned. stephens does not carry any weight. stock down 2% however, it is a very volatile stock. down early, will bounce back if market does.
and yet there is a downgrade this morning from Stephens and Co.......who is that?
while 411 seems like a good price, and after going from 480 to 407, a 15% correction, there still is some pressure on BIIB and all the biotechs. be careful here.
slow down matt. while nice to see, a few minutes of powering higher might be too soon to get that excited. let's see if it holds.